AlzBiomarker
MCI-AD vs MCI-Stable: YKL-40 (CSF)
Meta-analysis Results: Meta-analysis of three comparisons showed that baseline levels of YKL-40 in the cerebrospinal fluid were significantly higher in people with mild cognitive impairment who went on to develop Alzheimer’s dementia compared to levels in those who had not declined at follow-up (effect size = 1.271, p <0.0001).
